Cargando…
RNAi for Treating Hepatitis B Viral Infection
Chronic hepatitis B virus (HBV) infection is one of the leading causes of liver cirrhosis and hepatocellular carcinoma (HCC). Current treatment strategies of HBV infection including the use of interferon (IFN)-α and nucleotide analogues such as lamivudine and adefovir have met with only partial succ...
Autores principales: | Chen, Yong, Cheng, Guofeng, Mahato, Ram I. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer US
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2217617/ https://www.ncbi.nlm.nih.gov/pubmed/18074201 http://dx.doi.org/10.1007/s11095-007-9504-0 |
Ejemplares similares
-
Antiviral RNAi: Translating Science Towards Therapeutic Success
por: Shah, Priya S., et al.
Publicado: (2011) -
Meta-Analysis of Drug Delivery Approaches for Treating Intracellular Infections
por: Shin, Sooyoung, et al.
Publicado: (2022) -
Defense Mechanisms against Viral Infection in Drosophila: RNAi and Non-RNAi
por: Swevers, Luc, et al.
Publicado: (2018) -
True story about HIV: theory of viral sequestration and reserve infection
por: Barasa, Simon Situma
Publicado: (2011) -
Advances with RNAi-Based Therapy for Hepatitis B Virus Infection
por: van den Berg, Fiona, et al.
Publicado: (2020)